Tiagabine Hydrochloride

CAS 145821-59-6 3 current records 3 historicalSmall Molecule

Who holds supplier records for Tiagabine Hydrochloride? 3 organisations hold a current record for Tiagabine Hydrochloride: an active US FDA Type II Drug Master File. A further 3 organisations have only historical (inactive) DMF filings. Recorded organisation countries for current records: India (2) and France (1).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 13 Nov 2026. How we read these records

Cite as: PharmaTek, “Tiagabine Hydrochloride: DMF and CEP holder records”, record as of 13 Nov 2026, pharmatek.co.uk/directory/api/tiagabine-hydrochloride

Reading the evidence

  • 3 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    2 of the 3 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 2 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (3)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Tiagabine Hydrochloride. Country is the organisation's recorded country, not necessarily the manufacturing site.

  • CHEMWERTH INC
    Active DMF 22033 · latest filing Sept 2008
    France
  • MSN LIFE SCIENCES PRIVATE LIMITED
    Active DMF 33494 · latest filing Dec 2018
    India Company GMP cert on record
  • Sun Pharmaceutical Industries Limited
    Active DMF 17978 · latest filing Jan 2005
    India Company GMP cert on record
Need Tiagabine Hydrochloride sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Historical records (3)

Organisations whose Type II DMFs for Tiagabine Hydrochloride are no longer active. These show a past filing, not current supply.

Show all 3 historical records
  • SIGNA SA DE CV
    Inactive DMF 27380 · filed Dec 2013
  • India · Inactive DMF 27286 · filed Aug 2013
  • RANBAXY LABORATORIES LTD
    Inactive DMF 18934 · filed Nov 2005

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Tiagabine Hydrochloride is an antiepileptic medication used to treat partial seizures. It works by inhibiting the reuptake of gamma-aminobutyric acid (GABA), thereby increasing its levels in the brain and aiding in the stabilization of neural activity.

Chemical identity

IUPAC name
(3R)-1-[4,4-bis(3-methylthiophen-2-yl)but-3-enyl]piperidine-3-carboxylic acid;hydrochloride
Canonical SMILES
CC1=C(SC=C1)C(=CCCN2CCC[C@H](C2)C(=O)O)C3=C(C=CS3)C.Cl
InChIKey
YUKARLAABCGMCN-PKLMIRHRSA-N
Synonyms
Gabitril API, abbott-70569 hydrochloride, abbott-70569.1, abbott-70569.hcl, abbott-705691, abt-569, gabatril, gabitril, nnc-05-0328, nnc-050328, no-05-0328, no-050328

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Anti-epileptic Agent
Physiologic effect
Decreased Central Nervous System Disorganized Electrical Activity

Therapeutic areas

NeurologyEpilepsy

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Tiagabine Hydrochloride?

3 organisations hold an active US FDA Type II Drug Master File or a CEP for Tiagabine Hydrochloride: CHEMWERTH INC (France), MSN LIFE SCIENCES PRIVATE LIMITED (India) and Sun Pharmaceutical Industries Limited (India). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Tiagabine Hydrochloride Drug Master Files are active?

CHEMWERTH INC (DMF 22033), MSN LIFE SCIENCES PRIVATE LIMITED (DMF 33494) and Sun Pharmaceutical Industries Limited (DMF 17978). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Tiagabine Hydrochloride records mean?

3 organisations have only inactive Type II DMFs for Tiagabine Hydrochloride. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

How do I qualify a Tiagabine Hydrochloride supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Tiagabine Hydrochloride?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.